(Ipsilateral) :

Qisheng Hao1, Qingze Li1, Hongliang Liu2

  • 1Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong Province, China; Department of Retroperitoneal Tumor Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong Province, China.

概括

与完全切除 (CR) 相比,TRL可能会改善 retroperitoneal liposarcoma (RPLS) 患者的生存结果. 已开发的预后诺姆图显示了临床应用的潜力,用于预测结果.

相关概念视频